| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 262,067 | 250,724 | 205,265 | 209,767 | | Cost of Revenue | (12,473) | 6,735 | 5,738 | 122,507 | | | Gross Profit | 274,540 | 243,989 | 199,527 | 87,260 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 255,644 | 225,970 | 196,806 | 90,053 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,464 | 18,019 | 2,721 | (2,793) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 18,896 | 18,019 | 2,721 | (2,793) | | Interest Expense | 4,846 | 5,043 | 5,543 | 4,936 | | Income Before Tax | 14,050 | 12,976 | (2,822) | (7,729) | | Income Tax Expense | 6,142 | 5,846 | (808) | (3,904) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,908 | 7,130 | (2,014) | (3,825) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,908 | 7,130 | (2,014) | (3,825) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,908 | $7,130 | ($2,014) | ($3,825) |
|
1.52% Nasdaq 0.00%
Income Statement
